As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all its educational activities through the disclosure of all relationships with ineligible companies and mitigation of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers, and presenters involved with this activity were required to disclose all financial relationships. The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and mitigated all identified conflicts of interest.
The following course directors, planners, reviewers, and speakers reported no financial relationships:
Linda Giering (ASNC staff)
The following course directors, planners, and speakers reported financial relationships:
Jamieson Bourque, MD, MHS, FASNC: Consultant fee: GE HealthCare
Martha Grogan, MD: Consulting fees: Alnylam, BridgeBio (Eidos), Janssen, Pfizer; Research Grants: Alnylam, AstraZeneca, BridgeBio (Eidos), Intellia, NovoNordisk; Steering Committees: AstraZeneca, NovoNordisk
Yuki Sahashi, MD, MSc, PhD: Consultant fees: m3.Inc.
Nishant R. Shah, MD, MPH, MSc, FASNC: Research funding: Pfizer, Inc.; Advisory Boards: BridgeBio and Pfizer, Inc.
Prem Soman, MD, PhD, MASNC, FRCP (UK): Consultant fees: Alnylam, BridgeBio (Eidos), Pfizer, Spectrum Dynamics; Research Grant: Pfizer Inc.
Victoria Anderson (ASNC staff): Stock Interest: Abbott Labs and AbbVie Inc.